{"id":29396,"date":"2026-10-26T12:35:00","date_gmt":"2026-10-26T19:35:00","guid":{"rendered":"https:\/\/getheally.com\/patients\/news\/can-glp-1-drugs-treat-osteoarthritis-copy"},"modified":"2026-10-27T07:46:31","modified_gmt":"2026-10-27T14:46:31","slug":"microdosing-glp-1-as-a-new-weight-loss-trend","status":"publish","type":"post","link":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend","title":{"rendered":"GLP-1 microdosing: does the new weight loss trend actually work?"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">GLP-1 microdosing means taking a much smaller dose of a GLP-1 medication, such as semaglutide or tirzepatide, than the standard dose used for weight loss. People try it hoping for fewer side effects, a lower cost, slower weight loss or health benefits beyond the scale. The trend took off on social media, but the science behind it is thin. As of 2026, no clinical trial has tested &#8220;microdosing&#8221; as a weight loss strategy. What we do know comes from studies of lower approved doses. Those show real but smaller weight loss than standard doses. Here&#8217;s what microdosing means, what the evidence says, where the risks are and safer ways to get the same goals.<\/span><\/p>\n<h2 id=\"key-takeaways\"><span style=\"font-weight: 400;\">Key takeaways<\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">&#8220;Microdosing&#8221; isn&#8217;t a medical term. It usually means taking a fraction of a standard GLP-1 dose, often about a quarter<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">No clinical trial has tested GLP-1 microdosing for weight loss as of 2026, and it&#8217;s an off-label use<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Lower doses still cause some weight loss. In an early semaglutide study, the lowest dose led to about 6% weight loss over a year, vs about 14% at the highest dose tested<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Lower doses usually mean fewer digestive side effects, but they don&#8217;t remove the medication&#8217;s risks<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The biggest risks come from compounded products, splitting doses yourself and adjusting doses without medical supervision<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Lower approved doses, slower dose increases and planned maintenance doses can achieve many of the same goals safely<\/span><\/li>\n<\/ul>\n<h2 id=\"what-is-glp-1-microdosing\"><span style=\"font-weight: 400;\">What is GLP-1 microdosing?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">GLP-1 medications mimic a natural gut hormone that reduces appetite, slows stomach emptying and helps control blood sugar. The main ones are <\/span><a href=\"https:\/\/getheally.com\/patients\/semaglutide\"><span style=\"font-weight: 400;\">semaglutide<\/span><\/a><span style=\"font-weight: 400;\"> (Wegovy, Ozempic) and <\/span><a href=\"https:\/\/getheally.com\/patients\/tirzepatide\"><span style=\"font-weight: 400;\">tirzepatide<\/span><\/a><span style=\"font-weight: 400;\"> (Zepbound, Mounjaro), which also acts on a second hormone, GIP.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Standard weight loss treatment starts at a low dose and increases every 4 weeks to a maintenance dose:<\/span><\/p>\n<table>\n<thead>\n<tr>\n<th><b>Medication<\/b><\/th>\n<th><b>Starting dose<\/b><\/th>\n<th><b>Standard maintenance doses<\/b><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span style=\"font-weight: 400;\">Wegovy (semaglutide)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">0.25 mg weekly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1.7 or 2.4 mg weekly<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Zepbound (tirzepatide)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2.5 mg weekly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">5, 10 or 15 mg weekly<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">Microdosing usually means staying well below these doses. On social media, it can describe anything from 0.1 mg of semaglutide a week to 1 to 2 mg of tirzepatide, sometimes taken every 10 to 14 days instead of weekly. Since there&#8217;s no official definition, two people who say they&#8217;re &#8220;microdosing&#8221; may be doing very different things.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This is different from medically supervised dosing, where a provider keeps you on a lower approved dose because it works well for you. That&#8217;s a normal part of care, and it&#8217;s backed by evidence.<\/span><\/p>\n<h2 id=\"why-people-try-microdosing-glp-1s\"><span style=\"font-weight: 400;\">Why people try microdosing GLP-1s<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">The most common reasons are:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Fewer side effects.<\/b><span style=\"font-weight: 400;\"> Nausea, vomiting and diarrhea are the main reasons people stop GLP-1 medications<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Lower cost.<\/b><span style=\"font-weight: 400;\"> A smaller dose can make a vial or pen last longer<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Slower, gentler weight loss.<\/b><span style=\"font-weight: 400;\"> Some people want to avoid rapid changes, such as facial volume loss, often called <\/span><a href=\"https:\/\/getheally.com\/patients\/news\/what-is-ozempic-face-and-how-to-treat-it\"><span style=\"font-weight: 400;\">&#8220;Ozempic face&#8221;<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Weight maintenance.<\/b><span style=\"font-weight: 400;\"> Some people want a lower dose after reaching their goal weight<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Benefits beyond weight loss.<\/b><span style=\"font-weight: 400;\"> Some hope for effects on inflammation, cravings, energy or long-term health, even without much weight to lose<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">These are reasonable goals. The question is whether microdosing actually delivers them, and at what risk.<\/span><\/p>\n<h2 id=\"what-the-research-says-about-glp-1-microdosing\"><span style=\"font-weight: 400;\">What the research says about GLP-1 microdosing<\/span><\/h2>\n<h3 id=\"no-trial-has-tested-microdosing-directly\"><span style=\"font-weight: 400;\">No trial has tested microdosing directly<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">As of 2026, no randomized clinical trial has studied GLP-1 microdosing for weight loss. No phase 3 trial has tested semaglutide below 0.25 mg a week or tirzepatide below 2.5 mg a week for weight loss. A 2026 narrative review in <\/span><i><span style=\"font-weight: 400;\">Cureus<\/span><\/i><span style=\"font-weight: 400;\"> described microdosing as &#8220;an emerging pragmatic approach&#8221; but said direct evidence is limited, and that more research is needed. Experts at Cedars-Sinai put it more bluntly. They said there&#8217;s no evidence that low-dose or intermittent use leads to meaningful, lasting weight loss.<\/span><\/p>\n<h3 id=\"what-lower-doses-can-do\"><span style=\"font-weight: 400;\">What lower doses can do<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The best clues come from older dose-finding studies and lower approved doses:<\/span><\/p>\n<table>\n<thead>\n<tr>\n<th><b>Study<\/b><\/th>\n<th><b>Dose<\/b><\/th>\n<th><b>Average weight loss<\/b><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span style=\"font-weight: 400;\">Semaglutide phase 2 trial (O&#8217;Neil, <\/span><i><span style=\"font-weight: 400;\">Lancet<\/span><\/i><span style=\"font-weight: 400;\"> 2018), 52 weeks<\/span><\/td>\n<td><span style=\"font-weight: 400;\">0.05 mg daily (about 0.35 mg a week)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">About 6%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Same trial<\/span><\/td>\n<td><span style=\"font-weight: 400;\">0.4 mg daily (about 2.8 mg a week)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">About 14%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Same trial<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Placebo<\/span><\/td>\n<td><span style=\"font-weight: 400;\">About 2%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">SURMOUNT-1 (tirzepatide), 72 weeks<\/span><\/td>\n<td><span style=\"font-weight: 400;\">5 mg weekly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">15.0%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">SURMOUNT-1<\/span><\/td>\n<td><span style=\"font-weight: 400;\">15 mg weekly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">20.9%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">STEP 1 (semaglutide), 68 weeks<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2.4 mg weekly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">14.9%<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">Two things stand out. First, even low doses of semaglutide led to meaningful weight loss compared with placebo. Second, weight loss clearly rose with dose. Lower doses work, but they work less.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The 5 mg tirzepatide result is worth noting. It&#8217;s an approved maintenance dose, and it led to 15% weight loss on average. That&#8217;s the kind of &#8220;lower dose&#8221; approach that has strong evidence behind it. For more on tirzepatide specifically, see <\/span><a href=\"https:\/\/getheally.com\/patients\/news\/what-is-tirzepatide-microdosing-and-can-lower-doses-be-effective\"><span style=\"font-weight: 400;\">can lower doses of tirzepatide be effective<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<h3 id=\"what-about-health-benefits-beyond-weight-loss\"><span style=\"font-weight: 400;\">What about health benefits beyond weight loss?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">GLP-1 medications have proven heart, kidney and liver benefits at standard doses. Whether very low doses keep any of these benefits is unknown. Claims that microdosing reduces inflammation, improves longevity or boosts energy are mostly based on theory, small case reports and patient stories, not trials.<\/span><\/p>\n<h2 id=\"possible-benefits-of-glp-1-microdosing\"><span style=\"font-weight: 400;\">Possible benefits of GLP-1 microdosing<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Based on what we know about lower doses, microdosing might offer:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Fewer digestive side effects.<\/b><span style=\"font-weight: 400;\"> Side effects like nausea tend to rise with dose, so a lower dose usually means fewer of them<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Modest appetite control<\/b><span style=\"font-weight: 400;\"> for people who don&#8217;t need large weight loss<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>A gentler option<\/b><span style=\"font-weight: 400;\"> for people who couldn&#8217;t tolerate standard dose increases<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>A lower cost per month,<\/b><span style=\"font-weight: 400;\"> in some cases<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">These possible benefits come with an important trade-off: less weight loss and uncertain long-term effects.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">GLP-1 care at Heally: <\/span><a href=\"https:\/\/getheally.com\/patients\/wegovy\"><span style=\"font-weight: 400;\">Wegovy<\/span><\/a><span style=\"font-weight: 400;\"> \u00b7 <\/span><a href=\"https:\/\/getheally.com\/patients\/zepbound\"><span style=\"font-weight: 400;\">Zepbound<\/span><\/a><span style=\"font-weight: 400;\"> \u00b7 <\/span><a href=\"https:\/\/getheally.com\/patients\/wegovy-pills\"><span style=\"font-weight: 400;\">Wegovy pills<\/span><\/a><\/p>\n<h2 id=\"the-risks-of-glp-1-microdosing\"><span style=\"font-weight: 400;\">The risks of GLP-1 microdosing<\/span><\/h2>\n<h3 id=\"dosing-errors-with-compounded-products\"><span style=\"font-weight: 400;\">Dosing errors with compounded products<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Many microdosing plans rely on compounded semaglutide or tirzepatide, measured with a syringe. Compounded GLP-1s are not FDA approved, and the FDA has received hundreds of reports of problems linked to them, including dosing errors that led to hospital stays. Converting milligrams to units on a syringe is a common source of mistakes. Since the FDA declared the semaglutide and tirzepatide shortages over in 2025, pharmacies can no longer mass-produce copies of these drugs.<\/span><\/p>\n<h3 id=\"splitting-doses-yourself\"><span style=\"font-weight: 400;\">Splitting doses yourself<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">FDA-approved single-dose pens aren&#8217;t designed to deliver partial doses. Multi-dose devices, such as KwikPens and vials, deliver fixed doses. Trying to split them on your own can lead to inaccurate doses, contamination or wasted medicine.<\/span><\/p>\n<h3 id=\"less-weight-loss-than-expected\"><span style=\"font-weight: 400;\">Less weight loss than expected<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">If your goal is significant weight loss, a microdose may not be enough. You may spend months on a dose that doesn&#8217;t help much, while a standard approach could have worked.<\/span><\/p>\n<h3 id=\"the-same-safety-warnings-still-apply\"><span style=\"font-weight: 400;\">The same safety warnings still apply<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">A lower dose may cause fewer side effects, but it doesn&#8217;t remove the risks listed on the label. These include pancreatitis, gallbladder problems, low blood sugar with diabetes medicines and the boxed warning about thyroid C-cell tumors.<\/span><\/p>\n<h3 id=\"taking-glp-1s-without-a-medical-reason\"><span style=\"font-weight: 400;\">Taking GLP-1s without a medical reason<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Some people use microdosing to lose a few pounds without having obesity or a weight-related condition. Experts say this group is among the highest risk. Using GLP-1s without a medical need is also risky for people with a history of eating disorders.<\/span><\/p>\n<h2 id=\"safer-alternatives-to-microdosing\"><span style=\"font-weight: 400;\">Safer alternatives to microdosing<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Most of the goals behind microdosing can be reached with approved, supervised approaches:<\/span><\/p>\n<table>\n<thead>\n<tr>\n<th><b>Your goal<\/b><\/th>\n<th><b>Safer option to ask your provider about<\/b><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span style=\"font-weight: 400;\">Fewer side effects<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Stay on each dose longer than 4 weeks before increasing, or step back to the last dose you tolerated<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Slower weight loss<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Stop at a lower approved maintenance dose, such as Zepbound 5 mg or Wegovy 1.7 mg<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Lower cost<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Manufacturer self-pay programs, which start at $149 a month for the Wegovy pill and $299 a month for Zepbound through LillyDirect<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Weight maintenance<\/span><\/td>\n<td><span style=\"font-weight: 400;\">A planned maintenance dose after you reach your goal<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Avoiding needles<\/span><\/td>\n<td><span style=\"font-weight: 400;\">An oral GLP-1, such as the Wegovy pill<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">For timing your dose changes, see <\/span><a href=\"https:\/\/getheally.com\/patients\/news\/how-long-to-stay-on-each-glp-1-dose-level-before-increasing\"><span style=\"font-weight: 400;\">how long to stay on each GLP-1 dose before increasing<\/span><\/a><span style=\"font-weight: 400;\">. For what a maintenance phase looks like, read <\/span><a href=\"https:\/\/getheally.com\/patients\/news\/what-is-the-maintenance-dose-of-tirzepatide\"><span style=\"font-weight: 400;\">what is the maintenance dose of tirzepatide<\/span><\/a><span style=\"font-weight: 400;\"> and <\/span><a href=\"https:\/\/getheally.com\/patients\/news\/how-long-should-you-stay-on-the-maintenance-dose-of-wegovy\"><span style=\"font-weight: 400;\">how long to stay on the maintenance dose of Wegovy<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If side effects are the problem, practical steps often help more than a lower dose. See <\/span><a href=\"https:\/\/getheally.com\/patients\/news\/how-to-manage-zepbound-side-effects\"><span style=\"font-weight: 400;\">how to manage Zepbound side effects<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<h2 id=\"microdosing-for-weight-maintenance-what-we-know\"><span style=\"font-weight: 400;\">Microdosing for weight maintenance: what we know<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Weight maintenance is the most promising use of lower doses, but it&#8217;s still being studied. When people stop GLP-1 medications completely, most regain a large share of the weight they lost. In the SURMOUNT-4 trial, people who switched from tirzepatide to placebo regained much of their weight within a year. A lower ongoing dose may help some people keep the weight off with fewer side effects, but there&#8217;s no trial-tested plan for doing this yet.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If you&#8217;ve reached your goal, talk to your provider about stepping down gradually and tracking your weight closely, rather than switching to a self-directed microdose.<\/span><\/p>\n<h2 id=\"who-should-avoid-glp-1-microdosing\"><span style=\"font-weight: 400;\">Who should avoid GLP-1 microdosing<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">GLP-1 medications, at any dose, aren&#8217;t right for:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">People with a personal or family history of medullary thyroid carcinoma or MEN 2<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">People with a history of pancreatitis<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">People who are pregnant, trying to get pregnant or breastfeeding<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">People with a history of eating disorders, unless closely supervised<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">People with diabetes who adjust doses without their provider, since blood sugar can change<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Before starting any GLP-1, your provider may check your blood sugar, kidney function and other markers with a <\/span><a href=\"https:\/\/getheally.com\/patients\/test-for-weight-loss\"><span style=\"font-weight: 400;\">weight loss lab panel<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<h2 id=\"the-bottom-line\"><span style=\"font-weight: 400;\">The bottom line<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">GLP-1 microdosing is a social media trend, not a proven treatment. No trial has tested it directly, and lower doses lead to less weight loss than standard doses. A lower dose can reduce side effects, but it doesn&#8217;t remove the medication&#8217;s risks. The biggest dangers come from compounded products, self-split doses and adjusting doses without supervision. If you want fewer side effects, slower weight loss or a lower cost, a provider can help you use approved doses in a way that fits you. That might mean slower increases, a lower maintenance dose or a self-pay program.<\/span><\/p>\n<p><i><span style=\"font-weight: 400;\">Curious whether a lower GLP-1 dose could work for you? <\/span><\/i><a href=\"https:\/\/getheally.com\/patients\/doctors\"><i><span style=\"font-weight: 400;\">Talk to a Heally provider<\/span><\/i><\/a><i><span style=\"font-weight: 400;\"> about a <\/span><\/i><a href=\"https:\/\/getheally.com\/patients\/weight-loss-prescription\"><i><span style=\"font-weight: 400;\">weight loss prescription<\/span><\/i><\/a><i><span style=\"font-weight: 400;\"> that fits your goals. See <\/span><\/i><a href=\"https:\/\/getheally.com\/patients\/how-it-works\"><i><span style=\"font-weight: 400;\">how Heally works<\/span><\/i><\/a><i><span style=\"font-weight: 400;\">.<\/span><\/i><\/p>\n<h2 id=\"faq\"><span style=\"font-weight: 400;\">FAQ<\/span><\/h2>\n<h3 id=\"what-is-glp-1-microdosing-2\"><span style=\"font-weight: 400;\">What is GLP-1 microdosing?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">It means taking a much smaller dose of a GLP-1 medication, such as semaglutide or tirzepatide, than the standard dose for weight loss. It&#8217;s not a medical term, there&#8217;s no standard microdose and it&#8217;s an off-label use.<\/span><\/p>\n<h3 id=\"does-microdosing-glp-1-work-for-weight-loss\"><span style=\"font-weight: 400;\">Does microdosing GLP-1 work for weight loss?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Lower doses can cause some weight loss, but less than standard doses. In an early semaglutide study, the lowest dose led to about 6% weight loss over a year, vs about 14% at the highest dose tested. No trial has tested microdosing as a strategy.<\/span><\/p>\n<h3 id=\"what-is-a-typical-glp-1-microdose\"><span style=\"font-weight: 400;\">What is a typical GLP-1 microdose?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">There&#8217;s no official microdose. People online describe anything from about 0.1 mg of semaglutide a week to 1 to 2 mg of tirzepatide, sometimes taken less often than weekly. That&#8217;s why it&#8217;s important to work with a provider rather than follow social media plans.<\/span><\/p>\n<h3 id=\"does-microdosing-reduce-glp-1-side-effects\"><span style=\"font-weight: 400;\">Does microdosing reduce GLP-1 side effects?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Usually, since side effects tend to rise with dose. But a lower dose doesn&#8217;t remove the medication&#8217;s serious risks, such as pancreatitis or gallbladder problems. Slowing dose increases under supervision can also reduce side effects.<\/span><\/p>\n<h3 id=\"is-glp-1-microdosing-safe\"><span style=\"font-weight: 400;\">Is GLP-1 microdosing safe?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">It hasn&#8217;t been studied enough to know. The biggest risks come from compounded products, splitting doses yourself and using GLP-1s without a medical reason. Under a provider&#8217;s supervision, using a lower approved dose is a safer approach.<\/span><\/p>\n<h3 id=\"can-i-microdose-wegovy-or-zepbound-pens\"><span style=\"font-weight: 400;\">Can I microdose Wegovy or Zepbound pens?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Single-dose pens aren&#8217;t designed for partial doses, and splitting them isn&#8217;t recommended. Ask your provider about a lower approved dose instead, such as Zepbound 5 mg or Wegovy 1.7 mg.<\/span><\/p>\n<h3 id=\"is-microdosing-a-good-way-to-maintain-weight-loss\"><span style=\"font-weight: 400;\">Is microdosing a good way to maintain weight loss?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">It might help some people, but it&#8217;s not proven. If you&#8217;ve reached your goal, talk to your provider about a planned maintenance dose rather than a self-directed microdose.<\/span><\/p>\n<h2 id=\"sources\"><span style=\"font-weight: 400;\">Sources<\/span><\/h2>\n<ol>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Panlilio MA, et al. &#8220;Multisystem Benefits of GLP-1 Microdosing: A Narrative Review.&#8221; <\/span><i><span style=\"font-weight: 400;\">Cureus<\/span><\/i><span style=\"font-weight: 400;\">, 2026. Summary via <\/span><a href=\"https:\/\/www.news-medical.net\/news\/20260901\/GLP-1-drugs-have-benefits-beyond-weight-loss-Could-microdoses-preserve-them.aspx\"><span style=\"font-weight: 400;\">news-medical.net<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Cedars-Sinai. &#8220;Can microdosing GLP-1s promote health and weight loss?&#8221; May 2026. <\/span><a href=\"https:\/\/www.cedars-sinai.org\/stories-and-insights\/expert-advice\/can-microdosing-glp-1s-promote-health-and-weight-loss\"><span style=\"font-weight: 400;\">cedars-sinai.org<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">O&#8217;Neil PM, et al. &#8220;Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.&#8221; <\/span><i><span style=\"font-weight: 400;\">The Lancet<\/span><\/i><span style=\"font-weight: 400;\">, 2018.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Jastreboff AM, et al. &#8220;Tirzepatide Once Weekly for the Treatment of Obesity&#8221; (SURMOUNT-1). <\/span><i><span style=\"font-weight: 400;\">New England Journal of Medicine<\/span><\/i><span style=\"font-weight: 400;\">, 2022. <\/span><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2206038\"><span style=\"font-weight: 400;\">nejm.org<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Wilding JPH, et al. &#8220;Once-Weekly Semaglutide in Adults with Overweight or Obesity&#8221; (STEP 1). <\/span><i><span style=\"font-weight: 400;\">New England Journal of Medicine<\/span><\/i><span style=\"font-weight: 400;\">, 2021.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">US Food and Drug Administration. &#8220;FDA&#8217;s concerns with unapproved GLP-1 drugs used for weight loss.&#8221; <\/span><a href=\"https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss\"><span style=\"font-weight: 400;\">fda.gov<\/span><\/a><\/li>\n<\/ol>\n<p><i><span style=\"font-weight: 400;\">This article is for educational purposes only and is not a substitute for professional medical advice. Never change your GLP-1 dose without talking to your prescriber. GLP-1 medications are available by prescription only, and semaglutide and tirzepatide carry an FDA boxed warning about the risk of thyroid C-cell tumors. Do not use them if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.<\/span><\/i><\/p>\n","protected":false},"excerpt":{"rendered":"GLP-1 microdosing means taking a much smaller dose of a GLP-1 medication, such as semaglutide or tirzepatide, than&hellip;\n","protected":false},"author":10,"featured_media":29399,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1835,1829,1794,1834],"tags":[1860,1699,2530,1831,1858,1797,1793,1830,2531,1832],"class_list":{"0":"post-29396","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-mounjaro","8":"category-tirzepatide","9":"category-weight-loss","10":"category-zepbound","11":"tag-glp-1","12":"tag-microdose","13":"tag-microdosing","14":"tag-mounjaro","15":"tag-osteoarthritis","16":"tag-ozempic","17":"tag-semaglutide","18":"tag-tirzepatide","19":"tag-trends","20":"tag-zepbound"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Microdosing GLP-1 as a new weight loss trend - Heally<\/title>\n<meta name=\"description\" content=\"Explore the trend of microdosing GLP-1 for weight loss. Learn about potential benefits, medical opinions, and available medications. Discover how Heally can connect you with experts to discuss personalized GLP-1 treatment options\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Microdosing GLP-1 as a new weight loss trend - Heally\" \/>\n<meta property=\"og:description\" content=\"Explore the trend of microdosing GLP-1 for weight loss. Learn about potential benefits, medical opinions, and available medications. Discover how Heally can connect you with experts to discuss personalized GLP-1 treatment options\" \/>\n<meta property=\"og:url\" content=\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend\" \/>\n<meta property=\"og:site_name\" content=\"Heally\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/getheally.com\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-26T19:35:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-27T14:46:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/10\/microdose_glp1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ben Krasne MD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ben Krasne MD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#article\",\"isPartOf\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend\"},\"author\":{\"name\":\"Ben Krasne MD\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/133ab039fcce2b4f2ef87ae214ab9211\"},\"headline\":\"GLP-1 microdosing: does the new weight loss trend actually work?\",\"datePublished\":\"2026-10-26T19:35:00+00:00\",\"dateModified\":\"2026-10-27T14:46:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend\"},\"wordCount\":2154,\"publisher\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#primaryimage\"},\"thumbnailUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/10\/microdose_glp1.jpg\",\"keywords\":[\"glp-1\",\"microdose\",\"Microdosing\",\"mounjaro\",\"osteoarthritis\",\"Ozempic\",\"semaglutide\",\"tirzepatide\",\"Trends\",\"zepbound\"],\"articleSection\":[\"Mounjaro\",\"Tirzepatide\",\"Weight Loss\",\"Zepbound\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend\",\"url\":\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend\",\"name\":\"Microdosing GLP-1 as a new weight loss trend - Heally\",\"isPartOf\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#primaryimage\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#primaryimage\"},\"thumbnailUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/10\/microdose_glp1.jpg\",\"datePublished\":\"2026-10-26T19:35:00+00:00\",\"dateModified\":\"2026-10-27T14:46:31+00:00\",\"description\":\"Explore the trend of microdosing GLP-1 for weight loss. Learn about potential benefits, medical opinions, and available medications. Discover how Heally can connect you with experts to discuss personalized GLP-1 treatment options\",\"breadcrumb\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#primaryimage\",\"url\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/10\/microdose_glp1.jpg\",\"contentUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/10\/microdose_glp1.jpg\",\"width\":1000,\"height\":667,\"caption\":\"woman happy after microsdosing glp-1 medication like ozempic\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/getheally.com\/patients\/news\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GLP-1 microdosing: does the new weight loss trend actually work?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#website\",\"url\":\"https:\/\/getheally.com\/patients\/news\/\",\"name\":\"Heally\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/getheally.com\/patients\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\",\"name\":\"Heally\",\"url\":\"https:\/\/getheally.com\/patients\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2019\/05\/heallybl.png\",\"contentUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2019\/05\/heallybl.png\",\"width\":152,\"height\":52,\"caption\":\"Heally\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/getheally.com\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/133ab039fcce2b4f2ef87ae214ab9211\",\"name\":\"Ben Krasne MD\",\"pronouns\":\"Meet Dr. Benjamin Krasne, M.D., an anesthesiology and preventive medicine physician specializing in longevity and metabolic health at Heally\",\"description\":\"Dr. Benjamin Krasne is a board-certified Anesthesiologist with deep expertise in preventive medicine, metabolic health, and longevity optimization. He earned his medical degree from the University of Miami Leonard M. Miller School of Medicine in 2013 and completed his Anesthesiology residency at the University of Miami \/ Jackson Health System - one of the largest and most complex medical centers in the United States, providing broad exposure to high-acuity patient care and pharmacology. Beyond his anesthesiology training, Dr. Krasne has built specialized expertise in the root causes of metabolic and age-related disease. His approach draws on cardiovascular, hormonal, and metabolic science to proactively optimize health markers rather than waiting for disease to manifest. He holds active medical licenses across U.S. states, reflecting his commitment to expanding access to evidence-based preventive care through telehealth. At Heally, Dr. Krasne is the primary medical reviewer for the platform's largest content category - GLP-1 weight loss medications, including semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), oral Wegovy, longevity protocols, NAD+ therapy, sermorelin, methylene blue, acarbose, and peptide therapies. His pharmacological background and preventive medicine focus make him ideally suited to review clinical content on metabolic optimization.\",\"sameAs\":[\"https:\/\/www.parkwayrestorativedentistry.com\/dr-benjamin-krasne\"],\"url\":\"https:\/\/getheally.com\/patients\/news\/author\/ben-krasne-md\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Microdosing GLP-1 as a new weight loss trend - Heally","description":"Explore the trend of microdosing GLP-1 for weight loss. Learn about potential benefits, medical opinions, and available medications. Discover how Heally can connect you with experts to discuss personalized GLP-1 treatment options","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend","og_locale":"en_US","og_type":"article","og_title":"Microdosing GLP-1 as a new weight loss trend - Heally","og_description":"Explore the trend of microdosing GLP-1 for weight loss. Learn about potential benefits, medical opinions, and available medications. Discover how Heally can connect you with experts to discuss personalized GLP-1 treatment options","og_url":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend","og_site_name":"Heally","article_publisher":"https:\/\/getheally.com","article_published_time":"2026-10-26T19:35:00+00:00","article_modified_time":"2026-10-27T14:46:31+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/10\/microdose_glp1.jpg","type":"image\/jpeg"}],"author":"Ben Krasne MD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ben Krasne MD","Est. reading time":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#article","isPartOf":{"@id":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend"},"author":{"name":"Ben Krasne MD","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/133ab039fcce2b4f2ef87ae214ab9211"},"headline":"GLP-1 microdosing: does the new weight loss trend actually work?","datePublished":"2026-10-26T19:35:00+00:00","dateModified":"2026-10-27T14:46:31+00:00","mainEntityOfPage":{"@id":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend"},"wordCount":2154,"publisher":{"@id":"https:\/\/getheally.com\/patients\/news\/#organization"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#primaryimage"},"thumbnailUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/10\/microdose_glp1.jpg","keywords":["glp-1","microdose","Microdosing","mounjaro","osteoarthritis","Ozempic","semaglutide","tirzepatide","Trends","zepbound"],"articleSection":["Mounjaro","Tirzepatide","Weight Loss","Zepbound"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend","url":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend","name":"Microdosing GLP-1 as a new weight loss trend - Heally","isPartOf":{"@id":"https:\/\/getheally.com\/patients\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#primaryimage"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#primaryimage"},"thumbnailUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/10\/microdose_glp1.jpg","datePublished":"2026-10-26T19:35:00+00:00","dateModified":"2026-10-27T14:46:31+00:00","description":"Explore the trend of microdosing GLP-1 for weight loss. Learn about potential benefits, medical opinions, and available medications. Discover how Heally can connect you with experts to discuss personalized GLP-1 treatment options","breadcrumb":{"@id":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#primaryimage","url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/10\/microdose_glp1.jpg","contentUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/10\/microdose_glp1.jpg","width":1000,"height":667,"caption":"woman happy after microsdosing glp-1 medication like ozempic"},{"@type":"BreadcrumbList","@id":"https:\/\/getheally.com\/patients\/news\/microdosing-glp-1-as-a-new-weight-loss-trend#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/getheally.com\/patients\/news"},{"@type":"ListItem","position":2,"name":"GLP-1 microdosing: does the new weight loss trend actually work?"}]},{"@type":"WebSite","@id":"https:\/\/getheally.com\/patients\/news\/#website","url":"https:\/\/getheally.com\/patients\/news\/","name":"Heally","description":"","publisher":{"@id":"https:\/\/getheally.com\/patients\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/getheally.com\/patients\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/getheally.com\/patients\/news\/#organization","name":"Heally","url":"https:\/\/getheally.com\/patients\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/","url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2019\/05\/heallybl.png","contentUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2019\/05\/heallybl.png","width":152,"height":52,"caption":"Heally"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/getheally.com"]},{"@type":"Person","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/133ab039fcce2b4f2ef87ae214ab9211","name":"Ben Krasne MD","pronouns":"Meet Dr. Benjamin Krasne, M.D., an anesthesiology and preventive medicine physician specializing in longevity and metabolic health at Heally","description":"Dr. Benjamin Krasne is a board-certified Anesthesiologist with deep expertise in preventive medicine, metabolic health, and longevity optimization. He earned his medical degree from the University of Miami Leonard M. Miller School of Medicine in 2013 and completed his Anesthesiology residency at the University of Miami \/ Jackson Health System - one of the largest and most complex medical centers in the United States, providing broad exposure to high-acuity patient care and pharmacology. Beyond his anesthesiology training, Dr. Krasne has built specialized expertise in the root causes of metabolic and age-related disease. His approach draws on cardiovascular, hormonal, and metabolic science to proactively optimize health markers rather than waiting for disease to manifest. He holds active medical licenses across U.S. states, reflecting his commitment to expanding access to evidence-based preventive care through telehealth. At Heally, Dr. Krasne is the primary medical reviewer for the platform's largest content category - GLP-1 weight loss medications, including semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), oral Wegovy, longevity protocols, NAD+ therapy, sermorelin, methylene blue, acarbose, and peptide therapies. His pharmacological background and preventive medicine focus make him ideally suited to review clinical content on metabolic optimization.","sameAs":["https:\/\/www.parkwayrestorativedentistry.com\/dr-benjamin-krasne"],"url":"https:\/\/getheally.com\/patients\/news\/author\/ben-krasne-md"}]}},"_links":{"self":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/29396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/comments?post=29396"}],"version-history":[{"count":12,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/29396\/revisions"}],"predecessor-version":[{"id":37995,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/29396\/revisions\/37995"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/media\/29399"}],"wp:attachment":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/media?parent=29396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/categories?post=29396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/tags?post=29396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}